γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse
Status:
Recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
Safety and Effectiveness of Donor γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia
Rescue Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Early Phase 1
Details
Lead Sponsor:
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Collaborator:
The First Affiliated Hospital of Soochow University